Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP4A | P20648 | 5/20 | 0.61 |
| ▸ | ATP4B | P51164 | 5/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | ATP1A1 | P05023 | 4/20 | 0.61 |
| ▸ | ATP1B1 | P05026 | 4/20 | 0.61 |
| ▸ | ATP1A3 | P13637 | 4/20 | 0.61 |
| ▸ | ATP1B2 | P14415 | 4/20 | 0.61 |
| ▸ | ATP1A2 | P50993 | 4/20 | 0.61 |
| ▸ | ATP1B3 | P54709 | 4/20 | 0.61 |
| ▸ | FXYD2 | P54710 | 4/20 | 0.61 |
| ▸ | ATP1A4 | Q13733 | 4/20 | 0.61 |
| ▸ | WDR5 | P61964 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | ENGASE | Q8NFI3 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 3/20 | 0.61 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | SARM1 | Q6SZW1 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1457476 | 1.00 | ATP4A (0.61) | ATP4AATP4BCYP2C9MAPTATP1A1 | |
| Dexlansoprazole SCHEMBL29950208 | 0.90 | CYP2C9 (0.63) | ATP4AATP4BCYP2C9MAPTATP1A1 | |
| Lansoprazole SCHEMBL1559598 | 0.90 | CYP2C9 (0.63) | ATP4AATP4BCYP2C9MAPTATP1A1 | |
| Dexlansoprazole SCHEMBL29353881 | 0.90 | CYP2C9 (0.63) | ATP4AATP4BCYP2C9MAPTATP1A1 | |
| Lansoprazole SCHEMBL29358567 | 0.90 | CYP2C9 (0.63) | ATP4AATP4BCYP2C9MAPTATP1A1 | |
| Lansoprazole SCHEMBL8597994 | 0.90 | CYP2C9 (0.63) | ATP4AATP4BCYP2C9MAPTATP1A1 | |
| Dexlansoprazole SCHEMBL29750802 | 0.90 | CYP2C9 (0.63) | ATP4AATP4BCYP2C9MAPTATP1A1 | |
| Lansoprazole SCHEMBL22366 | 0.90 | CYP2C9 (0.63) | ATP4AATP4BCYP2C9MAPTATP1A1 | |
| Dexlansoprazole SCHEMBL44975 | 0.90 | CYP2C9 (0.63) | ATP4AATP4BCYP2C9MAPTATP1A1 | |
| Dexlansoprazole SCHEMBL29598842 | 0.90 | CYP2C9 (0.63) | ATP4AATP4BCYP2C9MAPTATP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1337525-B8 | PROCESS FOR THE CRYSTALLIZATION OF (R)- OR (S)-LANSOPRAZOLE | TAKEDA PHARMACEUTICAL (JP) | 2011-10-05 | — | — | EP | disclosed |
| EP-2292612-A2 | Crystalline solvated forms of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole | Takeda Pharmaceutical Company Limited (JP) | 2011-03-09 | — | — | EP | disclosed |
| EP-1553929-A2 | CONTROLLED RELEASE PREPARATION | Takeda Pharmaceutical Company Limited (JP) | 2005-07-20 | — | — | EP | disclosed |
| EP-1513527-A1 | PRODRUGS OF IMIDAZOLE DERIVATIVES, FOR USE AS PROTON PUMP INHIBITORS IN THE TREATMENT OF E.G. PEPTIC ULCERS | Takeda Pharmaceutical Company Limited (JP) | 2005-03-16 | — | — | EP | disclosed |
| WO-2004035020-A2 | CONTROLLED RELEASE PREPARATION | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-04-29 | — | — | WO | disclosed |
| WO-2003105845-A1 | PRODRUGS OF IMIDAZOLE DERIVATIVES, FOR USE AS PROTON PUMP INHIBITORS IN THE TREATMENT OF E.G. PEPTIC ULCERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2003-12-24 | — | — | WO | disclosed |
| EP-1337525-A1 | PROCESS FOR THE CRYSTALLIZATION OF (R)- OR (S)-LANSOPRAZOLE | Takeda Chemical Industries, Ltd. (JP) | 2003-08-27 | — | — | EP | disclosed |
| WO-2002044167-A1 | PROCESS FOR THE CRYSTALLIZATION OF (R)- OR (S)-LANSOPRAZOLE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-06-06 | — | — | WO | disclosed |
| WO-1993012817-A1 | THERAPEUTIC COMBINATIONS USEFUL IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE | WARNER-LAMBERT COMPANY (US) | 1993-07-08 | — | — | WO | disclosed |